Catalyst Wire Dossier Catalyst Wire Dossier

YEZTUGO

LENACAPAVIR SODIUM · Gilead Sciences, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for YEZTUGO, covering 2025-06-18 to 2025-06-18. Get the full timeline:

Most recent: FDA Approved: YEZTUGO — Original Application (Gilead Sciences, Inc.)

See pricing